Another pathogenic mechanism that may operate in miR-17-92-dependent lymphomas is based on the associations between miR-17-92 over expression and translocations of the MYC gene, an oncogene that is a critical mediator of cell growth. The gene discussed is MYC; the disease is lymphoma.